NFE2L2 and Alzheimer disease: For example, systemic SFN treatment reduced mast cell infiltration, eosinophil count and serum IgE levels in a 2,4-dinitrochlorobenzene (DNCB)-induced AD mouse model (Wu et al., 2019), suggesting that Nrf2 activation also attenuates the inflammatory response.